. . . . . . . . . "The most commonly reported diagnosis treated was Major Depressive Disorder (72.2%), followed by Bipolar Disorder (15.1%), and Posttraumatic Stress Disorder (5.7%). Most providers (87.7%) reported administering ketamine via an intravenous route, with a minority reporting using an oral (22.8%) or an intranasal (19.3%) formulation." . . . . . . "Adults" . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "a+SdXYUrjVz/3ANtCRCiba5OLdfnIUAxEknfVaHCqdVph5YgYGqZwuBoVK1CWM0bmi3v2i7rSbgm5yXF+m+BLYfG+TrXxy2cCDHkr3lqvh2y81HsUlml6Qz9ljfnaAWa1pwSF94CveX7egAgQa0vhXx/XgxOBUBKglLZU4peWJM=" . . "2021-05-25T14:46:33.571+02:00"^^ . . . . .